PET scanning is important in lung cancer; but it has its limitations
نویسندگان
چکیده
منابع مشابه
FDG PET in the management of lung cancer
We describe a patient with newly diagnosed limy cancer. Staging was performed with CT and mediastinoscopy. FDG PET scan was performed and confirmed increased metabolic activity in the primary tumor as well as the hilar lymph node. Seven months after initial presentation, the patient was found to have two lytic lesions in the pelvis on plain radiograph. Hone scan was negative but PET demon...
متن کاملLung cancer screening: has its time come?
Reflecting lung cancer screening’s potential for complexity, the article in this issue by Drs. Brawley and Flenaugh points out that there are so many different solitary nodules found on the low-dose helical computerized tomography (LDCT) used for lung cancer screening that algorithms are being developed to more effectively and accurately distinguish benign lesions from malignant ones. The major...
متن کاملLung cancer screening has the potential to safe lives, but shall we do it?
Almost three decades ago several controlled studies failed to show that lung cancer screening by chest x-ray (CXR) and sputum cytology improves survival in a screened population. A number of subsequent studies using chest computed tomography (CT) in smokers revealed lesions suspect for cancer in around 20% and had a lung cancer detection rate of approx. 1%. Since these trials lacked a control a...
متن کاملCannabidiol Reduces Leukemic Cell Size – But Is It Important?
The anti-cancer effect of the plant-derived cannabinoid, cannabidiol, has been widely demonstrated both in vivo and in vitro. However, this body of preclinical work has not been translated into clinical use. Key issues around this failure can be related to narrow dose effects, the cell model used and incomplete efficacy. A model of acute lymphoblastic disease, the Jurkat T cell line, has been u...
متن کاملImmunotherapy for Lung Cancer: Has it Finally Arrived?
The possible link between infection/inflammation/immune activation and a cancer patient's outcome from both a causative and outcome point of view has long been postulated. Substantial progress in the understanding of tumor-associated antigens/epitopes, immune cellular subpopulations, cytokine pathways/expression, the tumor microenvironment, and the balance between tumor-immune suppression and s...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Respirology
سال: 2010
ISSN: 1323-7799
DOI: 10.1111/j.1440-1843.2010.01843.x